Latest filings (excl ownership)
8-K
1 Endo Investor Presentation September 2024
11 Sep 24
424B3
Prospectus supplement
29 Aug 24
10-Q
2024 Q2
Quarterly report
29 Aug 24
424B3
Prospectus supplement
27 Aug 24
8-K
Endo Announces Ceo Transition
27 Aug 24
8-K
Endo Reports Second-quarter 2024 Financial Results
27 Aug 24
EFFECT
Notice of effectiveness
1 Aug 24
S-8
Registration of securities for employees
31 Jul 24
424B3
Prospectus supplement
31 Jul 24
S-1/A
IPO registration (amended)
26 Jul 24
S-1
IPO registration
12 Jul 24
D/A
$170.57 mm in equity, sold $170.57 mm, 404 investors
6 May 24
D
Indefinite amount in equity / options, 55 investors
21 Mar 24
Latest ownership filings
No filings